#NewProfilePic

Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change bit.ly/2VpjPEQ (FREE) #gadolinium #CKD Commentary by Ali Abu-Alfa on JAMA Internal Medicine article ⬇️

#Set_your_priorities_and_use_your_time_wisely and then you will be able to accomplish anything We all have this one life to live. A fleeting shadow amongst all that exists in this vast univers. We have the ability to accomplish anything .. truly anything…lnkd.in/dXXRkVs

⚡️Are you a nephrology fellow or early career nephrologist? GlomCon is now accepting applications for the first class of its virtual glomerular disease fellowship. Work with an elite group of expert faculty. Learn, teach and network! Apply now at edu.glomcon.org

Great news today for chronic kidney disease patients and the nephrology world. In DAPA-CKD trial, the use of a SGLT2 inhibitor in CKD reduced the risk of adverse renal/patient outcomes #DAPACKD #CKD NEJM

T0c. Phosphate levels have been one of many modifiable markers we chase in a bid to reduce mortality among dialysis patients. Sadly, phosphate binders lower phosphate levels but not mortality(Swapnil Hiremath @hswapnil.medsky.social’s commentary on this: nephjc.com/news/landmark-…). #NephJC

Some of my urine sediment examination slides collection done the last 2 years of fellowship at #AUBMC #UrineMicroscopy Ali Abu-Alfa @KoubarSahar

AKI+ hematuria+ proteinuria. Dysmorphic RBC, RBC cast. Kidney biopsy: acute interstitial nephritis, no glomerular injury.??? #Urinesediment #UrineMicroscopy Jay R. Seltzer Juan Carlos Q Velez

Is the higher thromboembolic risk seen in nephrotic syndrome secondary to membranous nephropathy (MN) apply to the secondary MN cases, specifically lupus MN? @askrenal Richard J. Glassock

Check out the podcast on the TESTING trial. Big thank you to @hladunewich for leading the trial in Canada, to all the Canadian and international PIs, to the patients who participated, and Vlado Perkovic and entire Steering Committee for keeping the trial on track over the years

Finally, one of the Glomcon fellows!

Glad to share our review on corticosteroids in IgA nephropathy with great mentors: Sean Barbour Jonathan Barratt An update on corticosteroid treatment for IgA nephropathy : Current Opinion in Nephrology and Hypertension journals.lww.com/co-nephrolhype…

🙏 Researcher profile: Malak Ghaddar - bcrenal.ca/research/bc-ki…

Proud of my fellow Lebanese colleagues. Representing Lebanon and AUB at the #KidneyWk despite all the difficulties. Assaad A. EID

Dr Malak Ghaddar GN fellow from UBC Nephrology on prognostic factors in C3G/iMPGN. Largest study to date. n = 239 Potential role for proteinuria reduction 50% to < 1g/day as a definition for proteinuria remission. Malak Ghaddar #Kidneywk